¸Ê°±¶ìÍÑÑõµ¨ËáÄÆ(GCDA),GCDAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« SDS-PAGEøÆ×·¨,ZymogaphyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θµ°°×øԭÑÇȺ,pepsinogenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Snail1µ°°×,Snail1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« SLP-2µ°°×,SLP-2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« È©ÇâÒ¶Ëá¸Æ,LeucovorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« E-¸Æð¤µ°°×/²¡Àíѧ,E-cadherin/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¦Â-Á¬»·ËØ/²¡Àíѧ,¦Â-catenin/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×éÖ¯ÆðÔ´/²¡Àíѧ,histogenesis/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­¸Ø,transanalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ïã¹½¶àÌÇ×¢ÉäÒº,lentinasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×Ó·´Òå¹ÑºËÜÕËá,VEGF-ASODNÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¦Â-Smac»ùÒò,¦Â-SmacÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍâÒõ²¿,CunnusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Î¶¯Âö¹à×¢»¯ÁÆ,TAIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CD34/ÉúÎïºÏ³É,CD34/biosynthesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 賦µÀ¼äÖÊÁö-T1ϸ°û,GIST-T1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­Ð͸Æð¤¸½µ°°×,N-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« mTOR/p70S6KÐźÅͨ·,mTOR/p70S6KÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¦Î¸Çå·½,ChangweiqingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 18O±ê¼Ç,18O-labelingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÙÁö-°©,Adenoma-to-CancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« É«ËØÎ¸¾µ,ChromoendoscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö×ÁöÒÖÖÆËØ,OSMÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö×ÁöÒÖÖÆËØÊÜÌå,OSMRÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 3-(5¡ä-ôǼ׻ù-2¡ä-ß»à«)-1-ÜлùßÅßò,3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazoleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »ùÒòÄÉÃ׸´ºÏÎï,DNA-Nanoparticle(DNA-NP)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­Æ¤´©´Ì΢²¨Äý¹ÌÖÎÁÆ,PMCTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö±³¦°©Ç°ÇгýÊõ,DixonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶þ±½ÒÒÏ©Àà/·ÖÎö,stilbenes/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶¡ÍªÀà/·ÖÎö,butanones/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« éÎÜÎÉ¢,HuqisanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­Æ¤¾­¸Îµ¨¹ÜÖùÜÒýÁ÷,PTBDÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °ëë×Ì춬ø14,Caspase14Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¦Á-L-ÑÒÔåÌÇÜÕø/ѪҺ,alpha-L-Fucosidase/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¦Ã-¹È°±õ£×ªÒÆÃ¸/·ÖÎö,gamma-Gluyamyltransferase/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼×Ì¥µ°°×-L3,AFP-L3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Axinµ°°×,AxinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö±³¦³åÏ´,RectaldouchingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍÙÒºËữLewis X¿¹Ô­,SialylLewis-XÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°ûÍâÐźŵ÷½Ú¼¤Ã¸1,ERK1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÙÌåÔöÉú,hyperliferationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »·ÑõºÏø-2,¦Â-Á´½ÓËØ,Cyclooxgenase-2,¦Â-cateninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼¡ÏË»ùÒòµ÷½ÚÒò×Ó,MR1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈËʳµÀ°©Ï¸°û,Ec9706Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³Éµ°°×¼Ò×å,ForminÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« E-¸ÆÕ³ËØ,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÂÃ¹ËØ,tunicamycinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ż·¢Áö,IncidentalomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ËèÐÔÖ¬·¾Áö,MyelolipomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔöÖ³ÐÔϸ°ûºË¿¹Ô­,PCNAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢СÐÍ,miniatureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« MCNP³ÌÐò,MCNP codeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃÚÈéËØÁö,prolactinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈéÍ·×´/Íâ¿ÆÑ§,papillary/surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉÏÆ¤¸ÆÕ³¸½µ°°×,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« N-¼×»ùÑÇÏõ»ùëå,N-methyl-N-nitrosoureaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ËèÑùÖ¬·¾Áö,myelolipomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« p73µ°°×,p73 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾«ëß,SpermidineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ÏɼÍéÀà,taxoidsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÑÉïÖÐÆÚÒò×Ó,MidkineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºËØÁö/Õï¶Ï,Insulinoma/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­µûñ¼,TranssphenoidalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ñÐÔÐØÏÙÁö,malignant thymomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °°ÄÚ,IntrasellaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙÊÖÊõ,adrenalectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »¯Ñ§Ö°©¼Á,carcinogenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ƫä,HemianopiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ͼÏñºó´¦Àí¼¼Êõ,post-processingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µÍ¼×»ù»¯,hypomethylationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« P-¸ÆÕ³µ°°×,P-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÓÒ°¼ì²é,perimetryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÔ΢Çгý,microsurgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °ëÈéÌÇÄýËØ-3,galectin-3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¹ÌåÇгý,hypophysectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ç÷»¯Òò×ÓÊÜÌå-4,CXCR4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºÁö,insulinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Êȸõϸ°ûÁö/Õï¶Ï,Pheochromocytoma/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µÍ¶È¶ñÐÔ,low-degreeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Meninµ°°×,MeninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Êȸõϸ°ûÁö/²¡Àíѧ,pheochromocytoma/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÞ¹¦ÄÜ,NonfunctionalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȸßѪÌÇËØÁö,GlucagonomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ËɹûÌåĸϸ°ûÁö,pineoblastomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Çå¼×,thyroidectomÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« DACH1µ°°×,DACH1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙÖ×Áö/²¡Àíѧ/Õï¶Ï,Cavernous/pathology/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÈËáÁ£Ï¸°û/²¡Àíѧ,Oxyphilic/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼äôǼ×ÉöÉÏÏÙËØÀàÎïÖÊ,metanephrinesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 4-ôÇ»ùËûĪÎô·Ò,4-hydroxytamoxifenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Ö»¯ÐÍ/Õï¶Ï,Differentiated/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Ö»¯ÐÍ/ÖÎÁÆ,Differentiated/therÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÆ/µâЭͬתÔËÌå,Na+/I-symportorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« À¼ÈðëÄ,lanreotideTMÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Àà¸ÎËØÃ¸-1,Heparanase-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃÚÈéËØÐÍ´¹ÌåÏÙÁö,MacroprolactinomasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Gµ°°×żÁªÊÜÌå48,GPR48Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÈÉýÌÇËØÁö,glucagonomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¹ÌåÏÙÁö,Pituitary adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«